Hemofiltration and Plasmapheresis

Sepsis and septic shock remain a very complex matter. It is only by a better knowledge of the pathophysiology of this syndrome and a better insight into the role of the various pro-and anti-inflammatory mediators that new treatments can be tested. Hemofiltration or hemoperfusion remain invasive, with potential side effects for the patient. Hence, experimental research remains very important and should be performed before the onset of clinical trials in patients.